Black Deal 12 months of Premium for €49.99 instead of €74.99 12 months €49.99 instead of €74.99 until Sun, Dec 13
Get the deal

-madrid - FACEIT level 10, 2,671 ELO

Kazakhstan
On FACEIT since 2014 154 matches tracked 12 matches in 30 days
Last updated:

-madrid at a glance

Level 10 2,671 ELO best map Nuke (60%)
2,500-2,749 ELO

Last 20 matches compared with 2,994 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 37%
1.00
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.42 ConsistencyShare of matches with a rating of 0.90 or higher. 60%
K/R
0.72
better than 40% of players
2,500-2,749 ELO avg: 0.75
Last 12 months
ADR
80.4
better than 47% of players
2,500-2,749 ELO avg: 81.2
Last 12 months
Win rate
50%
better than 41% of players
2,500-2,749 ELO avg: 51%
Last 12 months

Facts

103 ELO Next goal ELO to the peak (2,774)
3 Comebacks last 90 days
Ancient Favorite map 49 of 154 matches
Nuke 60% Map pool tip weakest: Mirage 27%
19:00-2:00 Playing times most active
On Sundays Best time 62% win rate vs. 51%
FormMapsTiming

103 ELO away from the recorded peak (2,774). 3 wins after trailing at halftime (last 90 days). Most played: Ancient (49 of 154 matches). Strongest map: Nuke (60% win rate, 25 matches). Weakest: Mirage (27%, 11 matches). Plays most between 19:00 and 2:00 (based on 154 matches). Best results on Sundays: 62% win rate vs. 51% overall (39 matches).

About -madrid

-madrid plays CS2 on FACEIT level 10 with 2,671 ELO. The stats cover 154 matches. The strongest map is Nuke with a 60% win rate in 25 matches. Most played: Ancient with 49 matches and a 55% win rate. Biggest strength: Utility damage per round at 7.0, better than 97% of level 10 · 2,500-2,749 ELO players. -madrid won 3 matches after trailing at halftime (last 90 days). Last 20 matches: 10 wins, 10 losses, -30 ELO. -madrid does best on Sundays: 62% win rate in 39 matches.